- Home
- KROS vs MNTK Comparison
KROS vs MNTK Comparison
Compare KROS & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- MNTK
- Stock Information
- Founded
- KROS 2015
- MNTK 1980
- Country
- KROS United States
- MNTK United States
- Employees
- KROS N/A
- MNTK N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- MNTK Natural Gas Distribution
- Sector
- KROS Health Care
- MNTK Utilities
- Exchange
- KROS Nasdaq
- MNTK Nasdaq
- Market Cap
- KROS 589.8M
- MNTK 622.2M
- IPO Year
- KROS 2020
- MNTK 2021
- Fundamental
- Price
- KROS $11.84
- MNTK $4.51
- Analyst Decision
- KROS Buy
- MNTK Hold
- Analyst Count
- KROS 11
- MNTK 2
- Target Price
- KROS $45.33
- MNTK $6.00
- AVG Volume (30 Days)
- KROS 2.1M
- MNTK 164.7K
- Earning Date
- KROS 02-26-2025
- MNTK 03-13-2025
- Dividend Yield
- KROS N/A
- MNTK N/A
- EPS Growth
- KROS N/A
- MNTK 42.11
- EPS
- KROS N/A
- MNTK 0.16
- Revenue
- KROS $651,000.00
- MNTK $194,849,000.00
- Revenue This Year
- KROS $303.27
- MNTK $21.28
- Revenue Next Year
- KROS N/A
- MNTK $31.59
- P/E Ratio
- KROS N/A
- MNTK $28.44
- Revenue Growth
- KROS 8037.50
- MNTK 9.63
- 52 Week Low
- KROS $9.78
- MNTK $3.38
- 52 Week High
- KROS $73.00
- MNTK $7.75
- Technical
- Relative Strength Index (RSI)
- KROS 24.87
- MNTK 56.40
- Support Level
- KROS $10.95
- MNTK $4.18
- Resistance Level
- KROS $11.63
- MNTK $4.24
- Average True Range (ATR)
- KROS 0.87
- MNTK 0.25
- MACD
- KROS 1.31
- MNTK 0.04
- Stochastic Oscillator
- KROS 30.60
- MNTK 60.00
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.